Hydrochloric Acid

Hydrochloric Acid

SCHEMBL7070348

CCCNC(=O)C[n+]1cccc(-c2cc(Cc3ccccc3)n[nH]2)c1.[Cl-]

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 3/20 0.44
KMT2A Q03164 2/20 0.36
GSK3B P49841 2/20 0.36
ALDH1A1 P00352 2/20 0.36
LMNA P02545 2/20 0.35
BACE1 P56817 2/20 0.35
APOBEC3A P31941 1/20 0.35
APOBEC3G Q9HC16 1/20 0.35
MTNR1A P48039 1/20 0.35
MTNR1B P49286 1/20 0.35
GSK3A P49840 1/20 0.34
KDM4E B2RXH2 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1194003 0.83 MAPK8 (0.39) HSP90AA1KMT2AALDH1A1LMNA
SCHEMBL6597984 0.82 MAPK8 (0.39) HSP90AA1KMT2AALDH1A1
SCHEMBL6596014 0.81 KMT2A (0.47) KMT2AALDH1A1LMNAKDM4E
Bromide SCHEMBL1193597 0.81 KMT2A (0.49) KMT2AALDH1A1LMNAKDM4E
Hydrochloric Acid SCHEMBL1194824 0.80 ALDH1A1 (0.42) KMT2AALDH1A1
SCHEMBL6598432 0.79 KMT2A (0.43) KMT2AALDH1A1
Hydrochloric Acid SCHEMBL1194041 0.78 ALDH1A1 (0.38) KMT2AALDH1A1LMNAKDM4E
Hydrochloric Acid SCHEMBL6597610 0.78 MAPK8 (0.36) KMT2AALDH1A1
Hydrochloric Acid SCHEMBL1194183 0.78 LMNA (0.56) KMT2AALDH1A1LMNAKDM4E
SCHEMBL6595709 0.77 ALDH1A1 (0.38) KMT2AALDH1A1LMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030045554-A1 Novel compounds for the management of aging-related and diabetic vascular complications, process for their preparation, therapeutic and cosmetic uses thereof TORRENT PHARMACEUTICALS LTD. 2003-03-06 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030045554-A1 Novel compounds for the management of aging-related and diabetic vascular complications, process for their preparation, therapeutic and cosmetic uses thereof AGER, GLA, F12 HSP90AA1 3897/4885KMT2A 3588/4885GSK3B 1133/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.